COMMUNIQUÉS West-GlobeNewswire

-
Flexion Therapeutics to Report Second-Quarter 2018 Financial Results on August 7, 2018
30/07/2018 -
Retrophin Appoints Noah L. Rosenberg, M.D., as Chief Medical Officer
30/07/2018 -
Kura Oncology to Report Second Quarter 2018 Financial Results
30/07/2018 -
Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
30/07/2018 -
SeaSpine Reports Second Quarter 2018 Financial Results
30/07/2018 -
GenMark Diagnostics Reports Second Quarter 2018 Results
30/07/2018 -
Editas Medicine to Host Conference Call Discussing Second Quarter 2018 Corporate Update and Results
30/07/2018 -
Merit Medical Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters’ Over-Allotment Option
30/07/2018 -
CytomX Therapeutics to Announce Second Quarter 2018 Financial Results
30/07/2018 -
athenahealth Reports Second Quarter Fiscal Year 2018 Results
30/07/2018 -
Aeglea BioTherapeutics Announces Fall 2018 Medical Conference Schedule
30/07/2018 -
New York Moves Closer to Legalizing Adult-Use, Game Changer for Cannabis Industry -- CFN Media
30/07/2018 -
GlenBrook Health Center Named Great Place to Work
30/07/2018 -
Dynavax to Host Second Quarter 2018 Financial Results Conference Call
30/07/2018 -
FDA Grants Orphan Drug Designation to Surface Oncology’s SRF231 for the Treatment of Multiple Myeloma
30/07/2018 -
BrightGuard Installs Free Sunscreen Dispensers Throughout Los Angeles Beach Cities
30/07/2018 -
Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific Officer
30/07/2018 -
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
30/07/2018 -
Ossur Hf : Transactions in relation to share buyback program
30/07/2018
Pages